Uremic serum-induced calcification of human aortic smooth muscle cells is a regulated process involving Klotho and RUNX2
Open Access
- 11 October 2019
- journal article
- research article
- Published by Portland Press Ltd. in Bioscience Reports
- Vol. 39 (10)
Abstract
Vascular calcification (VC) is common in subjects with chronic kidney disease (CKD) and is associated with increased cardiovascular risk. It is an active process involving transdifferentiation of arterial smooth muscle cells (SMCs) into osteogenic phenotype. We investigated the ability of serum from CKD subjects to induce calcification in human SMCs in vitro (calcific potential of sera: CP), and associated changes in expression of Runt-related transcription factor 2 (RUNX2), SM22α, and Klotho. Sera from subjects with CKD (18 stage 3, 17 stage 4/5, and 29 stage 5D) and 20 controls were added to human cultured SMCs and CP quantified. The CP of CKD sera was greater (P) than that of controls, though not influenced by CKD stage. Modification of diet in renal disease estimated glomerular filtration rate (MDRD-4 eGFR) (P), serum phosphate (P=0.042), receptor activator of nuclear factor κappa-B ligand (RANKL) (P=0.001), parathyroid hormone (PTH) (P=0.014), and high-density lipoprotein (HDL)/cholesterol ratio (P=0.026) were independent predictors of CP accounting for 45% of variation. Adding calcification buffer (CB: calcium chloride [7 mM] and β-glycerophosphate [7 mM]) increased the CP of control sera to approximate that of CKD sera. CP of CKD sera was unchanged. CKD sera increased RUNX2 expression (P) in human SMCs and decreased SM22α expression (P). Co-incubating control but not CKD serum with CB further increased RUNX2 expression (P). Both SM22α and Klotho expression decreased significantly (P) in the presence of CKD serum, and were virtually abolished with stage 5D sera. These findings support active regulation by CKD serum of in vitro VC by induction of RUNX2 and suppression of SM22α and Klotho.Keywords
This publication has 28 references indexed in Scilit:
- KlothoCirculation, 2012
- Vascular Klotho Deficiency Potentiates the Development of Human Artery Calcification and Mediates Resistance to Fibroblast Growth Factor 23Circulation, 2012
- Calcium and osteoprotegerin regulate IGF1R expression to inhibit vascular calcificationCardiovascular Research, 2011
- High-phosphate-induced calcification is related to SM22α promoter methylation in vascular smooth muscle cellsJournal of Bone and Mineral Research, 2010
- Increased Risk of Chronic Kidney Disease in Elderly with Metabolic Syndrome and High Levels of C-Reactive Protein: Kahrizak Elderly StudyKidney and Blood Pressure Research, 2009
- A Bimodal Association of Vitamin D Levels and Vascular Disease in Children on DialysisJournal of the American Society of Nephrology, 2008
- Oxidative Stress Induces Vascular Calcification through Modulation of the Osteogenic Transcription Factor Runx2 by AKT SignalingJournal of Biological Chemistry, 2008
- Regulation of smooth muscle excitation and contractionNeurogastroenterology & Motility, 2008
- Cardiovascular Calcifications in Uremic PatientsJournal of the American Society of Nephrology, 2003
- β-Glycerophosphate Accelerates Calcification in Cultured Bovine Vascular Smooth Muscle CellsArteriosclerosis, Thrombosis, and Vascular Biology, 1995